GPRIN3 and Parkinson disease: The outcome of the study indicates a prevalent role of GPRIN3 in dopamine signaling in the striatum which can be linked with striatal dysfunction associated with the dopamine receptor, such as Parkinson's disease and psychiatric disorders (Karadurmus et al., 2019).